Update on atopic dermatitis - 03/04/25
Abstract |
Atopic dermatitis is the most common chronic inflammatory skin condition. This review highlights most recent advances in understanding and treating this debilitating disease. We summarize new insights regarding molecular endotypes and clinical phenotypes that characterize atopic dermatitis, the role of the skin microbiome, and improvements in diagnostic tools. We also emphasize recent scientific advancements in understanding the mechanisms driving atopic dermatitis pathogenesis and discuss the identification and implementation of new targeted treatment approaches that have revolutionized therapeutic options for affected patients.
Le texte complet de cet article est disponible en PDF.Key word : Atopic dermatitis
Abbreviations used : AD, CI, CTCL, DAHND, DAOSD, EASI, FDA, FLG, IGA, IRAK4, JAK, mAb, OR, OX40L, SCORAD, TEAE, TSLP
Plan
| The first 2 authors contributed equally to this article, and both should be considered first author. |
Vol 155 - N° 4
P. 1124-1132 - avril 2025 Retour au numéro
Article précédent
- Update on mast cell biology
- Hadas Tamar Pahima, Daniel F. Dwyer
- Targeting alarmins in asthma: From bench to clinic
- Ayobami Akenroye, Joshua A. Boyce, Hirohito Kita
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?